Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

JUAN RAFAEL DE LA HABA RODRIGUEZ2026-01-292026-01-29201510.1185/03007995.2015.10377302-s2.0-84930329118https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/26154Medicine (all)Medicine (all)Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancerresearch article